51˶

Mania and Menopause; ADHD Drugs Still Scarce; Era of Muscarinic Agonists?

— News and commentary from the psychiatry world

MedpageToday
Illustration of a brain shaped maze.

Perimenopause was linked with an -- but not schizophrenia spectrum disorders -- when compared with the late reproductive period. (Nature Mental Health)

Global issues like the are weighing on young people's mental health. (New York Times)

Despite signs from the FDA that manufacturers were catching up to meet demand, drugs to remain hard to find. (Axios)

Video game console ownership, along with increased game play, among study participants in Japan, an analysis suggested. (Nature Human Behavior)

The insomnia drug suvorexant (Belsomra) in older hospitalized adults, a placebo-controlled phase III trial found. (JAMA Network Open)

As an FDA decision nears on the muscarinic agonist xanomeline-trospium for schizophrenia -- which could represent the first new class of drug approved for the condition in decades -- PharmaVoice .

In children under 6 years of age with post-traumatic stress disorder (PTSD), after the PTSD-inducing event was the most commonly reported symptom. (Scientific Reports)

During the perinatal and postpartum periods, the proportions of anxiety disorders, depressive disorders, and PTSD were higher among people with (IDD) compared to those without IDD. (JAMA Network Open)

Researchers detailed the value of with clinical trial patients with schizophrenia. (Frontiers in Psychiatry)

A Manhattan judge ruled that lawsuits can't go forward. (Reuters)

In a small trial, a self-guided cognitive behavioral therapy mobile app for helped to reduce symptoms regardless of the type of incentive strategy used to promote engagement. (JAMA Network Open)

  • author['full_name']

    Kristen Monaco is a senior staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.